ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Kymera Therapeutics Inc

Kymera Therapeutics Inc (KYMR)

45.98
-1.04
(-2.21%)
Closed 27 November 8:00AM
45.98
0.00
( 0.00% )
Pre Market: 8:51PM

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 16.14M9.47M16.51M4.73M47.89M10.29M25.65M3.74M
Operating Income -38.63M-45.33M-43.38M-57.51M-19.31M-52.91M-50.93M-72.12M
Pre Tax Income -34.87M-40.93M-38.8M-52.87M-14.37M-48.56M-42.06M-62.49M
Net Income -34.87M-40.93M-38.8M-52.87M-14.37M-48.56M-42.06M-62.49M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -38.63M-45.33M-43.38M-57.51M-19.31M-52.91M-50.93M-72.12M
EBITDA -37.85M-44.45M-42.48M-55.49M-19.55M-51.45M-48.99M-70.14M
Year End 31 December 2023 201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 02.93M34.03M72.83M46.83M78.59M
Operating Income -21.45M-42.21M-46.3M-100.53M-161.26M-165.53M
Pre Tax Income -21.47M-41.25M-45.59M-100.22M-154.81M-146.96M
Net Income -21.47M-41.25M-54.64M-100.22M-154.81M-146.96M
Preferred Dividends 00-9.05M000
Basic Earnings Per Share (EPS) -9.1-13.405-1.219-1.945-2.813-2.649
EBIT -21.45M-42.21M-46.3M-100.53M-161.26M-165.53M
EBITDA -21.25M-41.38M-44.54M-98.13M-158.28M-161.97M